BTG3 and autoimmune disease: It should be noted that a significant difference was found between the HD and NHP groups considering the 1:80 cut-off; although the NHP group was represented by non-hematologic patients with no clinical history of autoimmune disease, they are still "pathological" subjects, enrolled in our center for other different clinical conditions and may be characterized by inflammatory profile that could be responsible for a non-specific ANA positivity.